Company: SIMA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076651
Chunk: 71

Company: SIM Acquisition Corp. I
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 71
---
intend”
and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements
are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual
results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our
filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are
qualified in their entirety by this paragraph.

The following discussion and
analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements
and the notes thereto included in this Report under “Item 1. Financial Statements”.

Overview

We are a blank check company
incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination. We have not selected
any Business Combination target. We may pursue an initial Business Combination in any business or industry, but are focusing on companies
in the healthcare industry. We intend to effectuate our initial Business Combination using cash from the proceeds of the Initial Public
Offering and the Private Placement, the proceeds of the sale of our shares in connection with our initial Business Combination (pursuant
to any forward purchase agreements or backstop agreements we may enter into following the consummation of the Initial Public Offering
or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, other securities
issuances, or a combination of the foregoing.

The issuance of additional
shares in connection with a Business Combination to the owners of the target or other investors:

●may significantly dilute the
equity interest of investors in the Initial Public Offering, which dilution would increase if the anti-dilution provisions in the
Class B Ordinary Shares resulted in the issuance of Class A Ordinary Shares on a greater than one-to-one basis upon conversion
of the Class B Ordinary Shares;

●may subordinate the rights of
holders of Class A Ordinary Shares if preference shares are issued with rights senior to those afforded our Class A Ordinary
Shares;

●could cause a change in control
if a substantial number of our Class A Ordinary Shares are issued, which may affect, among other things, our ability to use our
net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers